Origène Nyanguile

Origène Nyanguile is a professor of chemistry at the University of Applied Sciences in Sion/Switzerland. His lab focuses on the discovery of peptides inhibitors targeting RSV and on the development of site selective conjugation methods for ADCs and radioimmunoconjugates. Prior to joining his current faculty position, Dr. Nyanguile worked at Novartis in Gene Therapy and at J&J, where he worked in the field of Hepatis C Virus. His team contributed to the discovery and development of a non-nucleoside polymerase antiviral, TMC647055, up to Phase 2 clinical trial. Dr. Nyanguile holds a Master degree in Organic Chemistry from the University of Geneva, a Ph.D. in Peptide Chemistry from the University of Lausanne, and a postdoc in Chemical Biology from Harvard University.